News Archive
Cobimetinib (trade name: Cotellic) has been approved since November 2015 in combination with vemurafenib for the treatment of adults with advanced, i.e. metastatic or unresectable, melanoma with a BRAF V600 mutation.
Change Healthcare, a market leader in healthcare consumer engagement and cost and quality transparency, has joined forces with RxREVU to deliver an enhanced medication selection experience to help consumers, payers and providers make more informed decisions about treatment options, especially those pertaining to therapeutic alternatives.
Physicians, parents and coaches should be cautious when considering treating injured young athletes with platelet rich plasma (PRP), stem cells or other types of regenerative medicine, says a nationally recognized sports medicine clinician and researcher at the University of Miami Miller School of Medicine and UHealth Sports Medicine Institute.
For years, researchers have known that children who grow up in homes with high levels of conflict tend to have behavior and learning problems. But they didn't know why.
New research finds that omega-3 polyunsaturated fatty acids (PUFAs) found in seafood (long-chain omega-3s) may reduce the risk of precancerous colorectal polyps in women, enhance the muscular benefits of strength training in older women and improve eye health after corneal surgery.
› Verified 4 days ago